Hemophilia

• FDA label_change · 2024-01-31
  FDA Approved: HEMLIBRA — Supplemental Application (Genentech, Inc.)

  The FDA approved a supplemental application for Hemlibra (emicizumab) from Genentech, updating the product labeling.

• FDA label_change · 2019-07-25
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

  FDA approved a supplemental application for Desmopressin acetate by Meitheal Pharmaceuticals, resulting in a label update associated with th…

• FDA label_change · 2019-07-25
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Sagent Pharmaceuticals)

  FDA approved a supplemental application for Desmopressin Acetate from Sagent Pharmaceuticals, resulting in changes to the product labeling.

• FDA label_change · 2008-04-25
  FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)

  FDA approved a supplemental application for Desmopressin Acetate from Bauch & Lomb Incorporated, indicating changes to labeling or related r…